Clinical studies have shown no major side effects, though mild bloating or nausea can occur if taken on a very full stomach
Participants were randomly assigned to different treatment groups, ensuring a balanced distribution and minimizing potential biases
The rate slows somewhat between months 6 and 9 as your body approaches its new equilibrium
FDA warning letters, import alerts, or clinical trial failures remain ever-present risks in pharma
Generally, GLP-1 agonist medications are FDA approved for adults aged 18 years and older with certain body mass indexes (BMI) (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS)
It does not constitute medical advice or a formal diagnosis